Acquisition History / Mankind Pharma / Bharat Serums and Vaccines
Mankind Pharma Acquires Bharat Serums and Vaccines
Announced July 25, 2024 — $1.54B
What happened
Mankind Pharma agreed to buy 100% of Bharat Serums and Vaccines from Advent International for an enterprise value of about Rs 13,630 crore, closing at Rs 13,768 crore after adjustments. BSV sells women's health and fertility drugs and anti-venom products, making Mankind a leader in Indian women's health therapies.
- Acquirer
- Mankind Pharma
- Target
- Bharat Serums and Vaccines
- Announced
- July 25, 2024
- Price
- $1.54B
- Industry
- Pharmaceuticals / biologics
- Buyer type
- Strategic acquirer
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Mankind Pharma acquire Bharat Serums and Vaccines?
Mankind Pharma acquired Bharat Serums and Vaccines on July 25, 2024. This was Mankind Pharma's 1st publicly tracked acquisition out of 1 we have on record.
How much did Mankind Pharma pay for Bharat Serums and Vaccines?
Mankind Pharma paid $1.54B for Bharat Serums and Vaccines.
What does Bharat Serums and Vaccines do?
Mankind Pharma agreed to buy 100% of Bharat Serums and Vaccines from Advent International for an enterprise value of about Rs 13,630 crore, closing at Rs 13,768 crore after adjustments. BSV sells women's health and fertility drugs and anti-venom products, making Mankind a leader in Indian women's health therapies.
What other Pharmaceuticals / biologics companies has Mankind Pharma acquired?
Bharat Serums and Vaccines is Mankind Pharma's only publicly tracked acquisition in Pharmaceuticals / biologics so far.